MAP4K4
- 2 trials, 1 with no results posted
- 2 of 2 trials sponsored by developers of drugs on it
- Cells1
Latest
Molecular Oncology
MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer
Experiments in human cellsTGF-β signalling